Biotech · Private company · Durham, NC, US
inSoma Bio, Inc.
Track this companyFree. Adds inSoma Bio, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Implantation (injection) of a new biomatrix for soft tissue support.Soft TissueClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- First-in-Human Safety Study for Fractomer™ BiomatrixNA · SUSPENDED · started Aug 11, 2025ClinicalTrials.gov NCT07151638 · fetched Nov 12, 2026
NIH awards2
- Enhancing Peripheral Nerve Repair with an Injectable Recombinant Polypeptide ScaffoldFiscal year 2024 · $296.2KNIH RePORTER 1R41NS135845-01A1 · fetched Nov 12, 2026
- An off the shelf alternative to fat transfer for soft tissue repairFiscal year 2024 · $294KNIH RePORTER 1R43GM153037-01A1 · fetched Nov 12, 2026